Literature DB >> 22197298

Cognitive phenotyping of amyloid precursor protein transgenic J20 mice.

Tim Karl1, Surabhi Bhatia, David Cheng, Woojin Scott Kim, Brett Garner.   

Abstract

Transgenic mice that express familial Alzheimer's disease mutant forms of the human amyloid precursor protein (hAPP) have proved to be invaluable in determining the impact that the neurotoxic amyloid-β peptide has in vivo. In addition to the propensity to accumulate cerebral amyloid plaques, a crucial characteristic of hAPP mouse models is their cognitive impairments. To date the most widely used test for analyzing cognitive impairment in hAPP mice is the Morris water maze (MWM) which, due to the fact that mice are not "natural" swimmers, may not always be the ideal paradigm to investigate cognitive behaviours. Furthermore, not all cognitive impairments have been replicated across research laboratories. In the current study, we characterised the cognitive abilities of the J20 transgenic mouse line (expressing the Swedish 670/671(KM->NL) and Indiana (717(V->F)hAPP mutations) and non-transgenic mice. Mice were assessed in the cheeseboard task (i.e., a 'dry version' of the MWM) and a variety of other cognitive paradigms to test fear conditioning, object recognition and short-term memory to broaden the understanding of the cognitive deficits in J20 mice. hAPP transgenic mice perform normally in tasks for fear conditioning, short-term object recognition and short-term memory of context familiarity. However, they were profoundly impaired in their spatial reference memory capabilities in the cheeseboard task. The cheeseboard task has potential to replace the MWM task in situations where the MWM is not suitable for particular mouse models.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22197298     DOI: 10.1016/j.bbr.2011.12.021

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  16 in total

1.  Wet or dry: translatable "water mazes" for mice and humans.

Authors:  Kerin K Higa; Jared W Young; Mark A Geyer
Journal:  J Clin Invest       Date:  2016-01-19       Impact factor: 14.808

2.  Sphingosine Kinase 2 Potentiates Amyloid Deposition but Protects against Hippocampal Volume Loss and Demyelination in a Mouse Model of Alzheimer's Disease.

Authors:  Mona Lei; Jonathan D Teo; Huitong Song; Holly P McEwen; Jun Yup Lee; Timothy A Couttas; Thomas Duncan; Rose Chesworth; Josefine Bertz; Magdalena Przybyla; Janet Van Eersel; Benjamin Heng; Gilles J Guillemin; Lars M Ittner; Thomas Fath; Brett Garner; Arne Ittner; Tim Karl; Anthony S Don
Journal:  J Neurosci       Date:  2019-10-22       Impact factor: 6.167

Review 3.  Can Animal Models Inform on the Relationship between Depression and Alzheimer Disease?

Authors:  Jennifer N K Nyarko; Maa O Quartey; Glen B Baker; Darrell D Mousseau
Journal:  Can J Psychiatry       Date:  2018-04-23       Impact factor: 4.356

4.  Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice.

Authors:  David Cheng; Jac Kee Low; Warren Logge; Brett Garner; Tim Karl
Journal:  Psychopharmacology (Berl)       Date:  2014-03-01       Impact factor: 4.530

5.  Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice.

Authors:  Alexandra J Mably; Wen Liu; Jessica M Mc Donald; Jean-Cosme Dodart; Frédérique Bard; Cynthia A Lemere; Brian O'Nuallain; Dominic M Walsh
Journal:  Neurobiol Dis       Date:  2015-07-26       Impact factor: 5.996

6.  Role of Abca7 in mouse behaviours relevant to neurodegenerative diseases.

Authors:  Warren Logge; David Cheng; Rose Chesworth; Surabhi Bhatia; Brett Garner; Woojin Scott Kim; Tim Karl
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

7.  Mesenchymal Stem Cell-Derived Exosomes Ameliorate Alzheimer's Disease Pathology and Improve Cognitive Deficits.

Authors:  Yi-An Chen; Cheng-Hsiu Lu; Chien-Chih Ke; Sain-Jhih Chiu; Fong-Shya Jeng; Chi-Wei Chang; Bang-Hung Yang; Ren-Shyan Liu
Journal:  Biomedicines       Date:  2021-05-24

8.  Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease.

Authors:  Amanda L Wright; Raphael Zinn; Barbara Hohensinn; Lyndsey M Konen; Sarah B Beynon; Richard P Tan; Ian A Clark; Andrea Abdipranoto; Bryce Vissel
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

9.  Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease.

Authors:  Scott J Webster; Adam D Bachstetter; Linda J Van Eldik
Journal:  Alzheimers Res Ther       Date:  2013-05-24       Impact factor: 6.982

10.  Icariin decreases the expression of APP and BACE-1 and reduces the β-amyloid burden in an APP transgenic mouse model of Alzheimer's disease.

Authors:  Lan Zhang; Cong Shen; Jin Chu; Ruyi Zhang; Yali Li; Lin Li
Journal:  Int J Biol Sci       Date:  2014-01-21       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.